Is reluctance to share Alzheimer’s disease biomarker status with a study partner a barrier to preclinical trial recruitment?

相似書籍

• Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer’s disease clinical trials
  由: Grill, Joshua, et al.
  出版: (2015)
• Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy
  由: Ryan, Mary M., et al.
  出版: (2019)
• Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials
  由: Nuño, Michelle M., et al.
  出版: (2019)
• Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer’s Disease Clinical Trial Recruitment
  由: Ryan, Mary M., et al.
  出版: (2021)
• Recruiting to preclinical Alzheimer's disease clinical trials through registries
  由: Grill, Joshua D.
  出版: (2017)